Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Lung Neoplasms 3Breast Neoplasms 3Prostatic Neoplasms 2Melanoma 2Hematologic Neoplasms 2Advanced Malignant Solid Neoplasm 2Urinary Bladder Neoplasms 1Syndrome 1Spondylitis, Ankylosing 1Rectal Neoplasms 1Psoriasis 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasm Metastasis 1Malignant Solid Neoplasm 1Malignant Female Reproductive System Neoplasm 1Lupus Erythematosus, Systemic 1Kidney Neoplasms 1Inflammatory Breast Neoplasms 1Inflammatory Bowel Diseases 1Hematopoietic and Lymphatic System Neoplasm 1HIV Infections 1Fatigue 1Endometrial Neoplasms 1Dyspnea 1Disease 1Crohn Disease 1Cough 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Standard of Care 1Practice Guidelines as Topic 1Methods 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Psoriasis × Educational Status × 30 days × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡